65051-31-2

Usage

Uses

Used in Pharmaceutical Synthesis:
[(2,4-dichlorobenzyl)sulfanyl]acetic acid is used as a key intermediate in the synthesis and preparation of various pharmaceuticals and drugs. Its unique chemical structure allows for the development of new medications with specific therapeutic properties.
Used in Antimicrobial Applications:
In the medical industry, [(2,4-dichlorobenzyl)sulfanyl]acetic acid is used as an antimicrobial agent for its demonstrated antibacterial and antifungal properties. It is commonly incorporated into the formulation of various medicinal products to combat bacterial and fungal infections, enhancing their overall effectiveness.
Used in Disease Treatment Research:
[(2,4-dichlorobenzyl)sulfanyl]acetic acid is also being investigated for its potential use in the treatment of various diseases and disorders, particularly those related to bacterial infections. Its unique functional group may offer new avenues for therapeutic intervention and the development of targeted treatments.

Upstream product

• 3926-62-3 sodium monochloroacetic acid 
• 94-99-5 2,4-Dichlorobenzyl chloride 
• 79-11-8 chloroacetic acid 
• 124-41-4 sodium methylate 

Downstream Products

• 300700-02-1 (2,4-dichloro-phenylmethanesulfonyl)-acetic acid 
• 65051-33-4 2-(2,4-dichlorobenzylmercapto)-acetohydroxamic acid 
• 65051-34-5 2,4-Dichlorobenzylsulphinyl-acetohydroxamic acid 

Relevant academic research and scientific papers

Phenylamidine derivatives

A compound having the general formula: STR1 wherein Ar is an aryl group (especially an α-naphthyl, β-naphthyl or phenyl group) which may be substituted by one or more C1-4 alkyl, C1-4 alkoxy, methylenedioxy halogen, CF3, NH2 or NO2 groups; A is a --CH2 --, --CHOH--, --CH2 O--, --CH2 S--, --CH2 NH--, --OCH2 --, --SCH2 --, --NH--, --NHCOCH2 --, --CH2 NHCH2 -- or --NHCH2 -- group; Y is O or NH; and B is a single bond and, when A is --CH2 --S, may be a --CH2 --, or --CH(CH3)-- group; and their acid addition salts when Y is NH and their metal salts when Y is O. The compounds and their salts have therapeutic utility in treatment of neuropsychic ailments.

Acetohydroxamic acids

The invention provides new acetohydroxamic acid derivatives, having interesting properties on the central nervous system, of the formula: R1 R2 R3 C-CO-NHOH, in which R2 and R3 are each hydrogen or C1-6 alkyl, and R1 is C1-6 alkyl Z1 Z2 N (where Z1 and Z2 are each phenyl, substituted phenyl, or cycloalkyl), substituted hydantoinyl, benzhydroxylcarboxamido, Z3 CH2 -- (where Z3 = optionally substituted aryl), Z4 -A- (where Z4 is optionally substituted phenyl or naphthyl, and A is --NH--, --N(C1-4 alkyl)--, --N(C5-6 cycloalkyl)--, --NHCO--, --N(C1-4 alkyl)CO--, --N(C5-6 cycloalkyl)CO--, --CONH--, --CON(C1-4 alkyl)--, --CON(C5-6 cycloalkyl)--, --NHCONH--, --N(C5 H6)CONH--, or --N(substituted phenyl)CONH--, optionally substituted benzimidazolyl, or an optionally substituted tricyclic radical, and their metal and acid addition salts.